[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"induction-of-birth\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:induction-of-birth":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,47,77],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":31,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":4},"100609466","open-randomized-feasibility-trial-on-the-safety-and-performance-of-the-inga-catheter-for-labor-induction-100609466",false,"NCT07214948","Open, Randomized Feasibility Trial on the Safety and Performance of the INGA Catheter for Labor Induction","An Open, Parallel-group, Randomized, Early Feasibility Trial to Evaluate the Initial Safety and Performance of the INGA Catheter in Labor Induction","INGA-RCT","Inclusion Criteria:\n\n* Pregnant women aged ≥18 and ≤56 years\n* An unripe cervix, ≤6 points according to the Bishop score assessment (0-10-point scale)\n* Planned induction of labor by balloon catheter method\n* Gestational age at the time of the study ≥ 37 weeks (gestational age confirmed by ultrasound before the 21st week of pregnancy)\n* Singleton pregnancy\n* Cephalic presentation\n* The subject understands the study information and signs the informed consent\n\nExclusion Criteria:\n\n* Preterm induction of labor (\\\u003C37 weeks of gestation)\n* Abnormal Cardiotocography (CTG) at inclusion\n* Spontaneous rupture of membranes at inclusion\n* Clinically significant vaginal bleeding with a need of hospitalization in the third trimester\n* Clinical active vaginal or uterine infection\n* Maternal Human Immunodeficiency Virus (HIV), hepatitis C, or hepatitis B\n* Uterine scar (including previous cesarean section)\n* Condition requiring immediate delivery of the fetus or mother\n* Presence of eclampsia\n* Severe Preeclampsia \\[Blood pressure (BP)≥ 160\u002F110 and any of the following: thrombocytopenia with platelet count \\\u003C100 × 10e9\u002FL, HELLP- syndrome ( Hemolysis, Elevated Liver enzymes and Low Platelets), progressive renal insufficiency, pulmonary edema \\]\n* Severe fetal growth restriction (Fetal Growth Restriction (FGR) fetal growth \\\u003C-2 SD\u002F\\\u003C10th percentile)\n* Estimated fetal weight ≥ 2 Standard Deviation \u002F≥ 95th percentile\n* Reduced amniotic fluid volume (deepest vertical pocket \\\u003C30 mill meter)\n* Breech or transverse fetal position\n* Multiple pregnancy\n* Vasa previa or placenta previa\n* Umbilical cord prolapses\n* Bishop score ≥6 on cervical assessment prior to labor induction\n* Receiving epidural anesthesia prior to catheter insertion\n* Refusal to participate in the study and\u002For insufficient language skills to understand the study information and\u002For consent form","FEMALE","18 Years","56 Years",{"count":21,"type":22},40,"ESTIMATED","INTERVENTIONAL",[25],"NA","This study investigates the safety and usability of the new INGA catheter for labor induction.\n\nLabor induction is common, with about one in three births being induced. In this study, the INGA catheter will be compared to a currently used method. The INGA catheter is a single-balloon device that works similarly to a Foley catheter but is made from different materials. Feedback will be collected from both healthcare professionals and participating women.",[28,29,30],"Induction of Birth","Cervical Ripening","Cervical Ripening and Induction of Labor",[32,33,34],"Induction of labor","Balloon Catheter","Cervical ripening","NOT_YET_RECRUITING","2026-05-22",{"date":38,"type":39},"2026-05-27","ACTUAL",{"date":41,"type":22},"2026-05",{"date":43,"type":22},"2026-10-30",{"name":45,"class":46},"Aalto University","OTHER",{"id":48,"slug":49,"hasResults":11,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":53,"eligibilityCriteria":54,"healthyVolunteers":55,"sex":17,"minAge":18,"maxAge":56,"enrollmentInfo":57,"targetDuration":4,"studyType":23,"phases":59,"briefSummary":60,"conditions":61,"keywords":4,"overallStatus":66,"whyStopped":4,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":76},"100561521","membrane-stripping-for-cervical-ripening-100561521","NCT06591247","Membrane Stripping for Cervical Ripening","Evaluation of Stripping for Cervical Ripening - A Randomized Controlled Study","Stripping","Inclusion Criteria:\n\n* Patients aged 18 and above\n* Patients with a cervical dilation of at least 1 cm\n* Full-term pregnancy\n* Cephalic presentation\n* No contraindication to vaginal delivery\n\nExclusion Criteria:\n\n* Patients with rupture of membranes\n* Patients who do not require cervical ripening and proceed directly to the delivery room for induction with oxytocin\n* Patients for whom the use of a double-balloon catheter\u002FPGE2 is contraindicated\n* Twin pregnancies\n* Pregnancies with macrosomic fetuses where vaginal delivery is contraindicated\n* Patients with maternal or fetal pathologies that do not allow for vaginal delivery due to concerns about fetal or maternal distress",true,"50 Years",{"count":58,"type":22},400,[25],"The goal of this interventional study is to evaluate the effectiveness of membrane stripping in cervical ripening compared to double balloon catheter induction.\n\nThe study population consists of women undergoing labor induction.\n\nThe main questions it aims to answer are:\n\n1. Is membrane stripping as effective as double balloon catheter induction in cervical ripening?\n2. What is the influence of membrane stripping on the time required for cervical ripening, delivery duration, and maternal and fetal outcomes compared to balloon induction.",[62,29,63,64,65,28],"Labor, Induced","Balloon Induction","Membrane Stripping","Pregnancy Related","RECRUITING","2026-04-10",{"date":69,"type":39},"2026-04-15",{"date":71,"type":39},"2024-08-07",{"date":73,"type":22},"2027-12-31",{"name":75,"class":46},"Meir Medical Center",1,{"id":78,"slug":79,"hasResults":11,"nctId":80,"briefTitle":81,"officialTitle":82,"acronym":83,"eligibilityCriteria":84,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":85,"targetDuration":4,"studyType":23,"phases":87,"briefSummary":88,"conditions":89,"keywords":91,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":95,"lastUpdatePostDateStruct":96,"startDateStruct":98,"completionDateStruct":100,"leadSponsor":102,"locationsCount":4},"100626180","evaluation-of-the-inga-sensor-system-for-fetal-and-uterine-monitoring-during-cervical-ripening-100626180","NCT07432282","Evaluation of the INGA Sensor System for Fetal and Uterine Monitoring During Cervical Ripening","Early Feasibility Study on the Safety and Performance of the INGA Sensor System for Fetal and Uterine Monitoring During Cervical Ripening With the INGA Balloon Catheter","INGA-SEN","Inclusion Criteria:\n\nPregnant women aged ≥18 and ≤56 years An unripe cervix, see below Planned induction of labor by mechanical balloon catheter method Gestational age at the time of the study ≥ 37 weeks Singleton pregnancy Cephalic presentation The subject understands the study information and signs the informed consent\n\nExclusion Criteria:\n\n* Preterm induction of labor (\\\u003C37 weeks of gestation)\n* Clinical active vaginal or uterine infection\n* Abnormal cardiotocography (CTG) at inclusion\n* Spontaneous rupture of membranes at inclusion\n* Clinically significant vaginal bleeding with need of hospitalization in the third trimester\n* Maternal HIV, hepatitis C, or hepatitis B\n* Condition requiring immediate delivery of the fetus or mother\n* Presence of eclampsia\n* Severe Preeclampsia (Blood pressure ≥160\u002F110 and any of the following: HELLP (Hemolysis, Elevated Liver enzymes, and Low Platelet count \\\u003C100 × 10 9\u002FL syndrome), progressive renal insufficiency, pulmonary edema)\n* Severe fetal growth restriction (FGR, growth \\\u003C -2 SD\u002F\\\u003C10th percentile)\n* Estimated fetal weight ≥ 2SD or ≥ 95th percentile\n* Breech or transverse fetal position\n* Multiple pregnancy\n* Vasa previa or placenta previa\n* Uterine scar (including previous caesarean section)\n* Umbilical cord prolapse\n* Bishop score ≥6 on cervical assessment prior to labor induction\n* Reduced amniotic fluid volume (deepest vertical pocket \\\u003C30 mm)\n* Receiving epidural anesthesia prior to catheter insertion\n* Refusal to participate in the study and\u002For insufficient language skills to understand the study information and\u002For consent form",{"count":86,"type":22},120,[25],"The goal of this clinical trial is to learn about the safety and performance of the INGA Sensor System when used with the INGA balloon catheter during cervical ripening for labor induction in pregnant individuals at term. Cervical ripening is a process used to prepare the cervix for labor.\n\nThe main questions it aims to answer are:\n\n* Is the INGA Sensor System safe to use during cervical ripening with the INGA balloon catheter?\n* How well does the sensor system measure uterine contractions and fetal heart rate during cervical ripening?\n* How does the use of the INGA balloon catheter affect cervical ripening and the time from induction to delivery?\n* How do participants and healthcare professionals evaluate the usability of the catheter and sensor system?\n\nAll participants in this study will receive the INGA balloon catheter with the attached sensor system. There is no comparison group.\n\nParticipants will:\n\n* Undergo routine assessments before labor induction, including medical history review, cervical examination, blood pressure and heart rate measurement, and fetal heart rate monitoring\n* Have the INGA balloon catheter placed in the cervix by a trained physician\n* Have a small sensor device attached to the external end of the catheter\n* Undergo standard fetal heart rate monitoring after placement\n* Keep the catheter and sensor in place until the catheter is expelled naturally or for up to 24 hours\n* Continue labor induction and delivery according to standard hospital practice\n* Complete a questionnaire about comfort and usability\n* Allow collection of information about labor, delivery, and newborn outcomes from medical records\n\nParticipation lasts from signing informed consent until hospital discharge.",[28,29,30,90],"Balloon Catheter for Labor Induction",[92,33,29,93,94],"Induction of labour","Uterine monitoring","Fetal monitoring","2026-02-19",{"date":97,"type":39},"2026-02-25",{"date":99,"type":22},"2026-05-01",{"date":101,"type":22},"2027-05-01",{"name":45,"class":46}]